Association between CYP2C19 gene polymorphisms and analgesic response to meperidine in emergency department patients with renal colic: a prospective observational study
Sena Baykara Sayili, Aylin Koseler, Bulent Erdur · 2026
Read Association between CYP2C19 gene polymorphisms and analgesic response to meperidine in emergency department patients with renal colic: a prospective observational study by Sena Baykara Sayili, Aylin Koseler, Bulent Erdur (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13471270.txt.
Description
Baykara Sayili and colleagues tested in 2026 whether variants of a drug-processing gene, CYP2C19, change how well the opioid meperidine relieves kidney stone pain in emergency patients. The prospective study enrolled 203 renal colic patients and gave each 100 milligrams of meperidine. Pain scores were recorded at baseline and at 15, 30, and 60 minutes. A further 102 people with other abdominal pain contributed genetic frequency data only. Gene types sort people into slow, normal, and rapid drug processors.
Genes mattered after the half hour. All groups eased similarly in the first 15 minutes. By 30 and 60 minutes, normal and rapid processors reported significantly lower pain and bigger percentage drops than moderate processors. One gene combination, written *1/*1, stood out for strong late relief. Age, sex, and stone position did not influence response. Eleven patients had side effects, mostly nausea and dizziness, none serious. The authors suggest genotype could one day tailor opioid choice in the emergency department.
Catalog record
| CREATOR | Sena Baykara Sayili, Aylin Koseler, Bulent Erdur |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 42 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |